SCHEMBL988236

SCHEMBL988236

CCOC(=O)/C(C#N)=C\c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.71
▸ PDCD1 Q15116 1/20 0.71
▸ CD274 Q9NZQ7 1/20 0.71
▸ ALDH1A1 P00352 12/20 0.70
▸ KDM4E B2RXH2 3/20 0.70
▸ POLB P06746 3/20 0.68
▸ KMT2A Q03164 6/20 0.66
▸ MEN1 O00255 5/20 0.66
▸ LMNA P02545 1/20 0.64
▸ PKM P14618 1/20 0.63
▸ HTT P42858 1/20 0.63
▸ TDP1 Q9NUW8 2/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.62
▸ NPC1 O15118 2/20 0.62
▸ RAB9A P51151 2/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ CASP3 P42574 1/20 0.62
▸ SENP8 Q96LD8 1/20 0.62
▸ SENP7 Q9BQF6 1/20 0.62
▸ SENP6 Q9GZR1 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988238 1.00 MAPT (0.71) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL278655 1.00 MAPT (0.71) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL2139678 0.92 ALDH1A1 (0.81) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL4317761 0.92 ALDH1A1 (0.81) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL2139676 0.92 ALDH1A1 (0.81) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL2581990 0.91 ALDH1A1 (0.67) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL2581988 0.91 ALDH1A1 (0.67) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL10719867 0.89 MAPT (0.82) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL10719869 0.89 MAPT (0.82) MAPTPDCD1CD274ALDH1A1KDM4E
SCHEMBL16131599 0.89 ALDH1A1 (0.64) MAPTPDCD1CD274ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076133-A Composite material, composition, preparation method of composite material, light-emitting device and display device TCL科技集团股份有限公司 2024-05-24 — — CN claimed
CN-117645581-A Method for synthesizing series of functional groups of photocatalytic inert C (sp 3) -H bond 浙江工业大学台州研究院 2024-03-05 — — CN claimed
US-20060085922-A1 Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant L'OREAL S.A. (FR) 2006-04-27 — — US claimed
EP-3883577-B1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY UNIV CASE WESTERN RESERVE (US) 2026-04-08 — — EP disclosed
US-12336982-B2 Compositions and methods of modulating short-chain dehydrogenase activity RODEO THERAPEUTICS CORPORATION (US) 2025-06-24 — — US disclosed
CN-120136926-A Catalyst for condensation reaction of aldehyde and ethyl cyanoacetate Knoevenagel and preparation method thereof 河北松辰医药科技有限公司 2025-06-13 — — CN disclosed
US-20250161277-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-05-22 — — US disclosed
CN-118076133-A Composite material, composition, preparation method of composite material, light-emitting device and display device TCL科技集团股份有限公司 2024-05-24 — — CN disclosed
CN-117645581-A Method for synthesizing series of functional groups of photocatalytic inert C (sp 3) -H bond 浙江工业大学台州研究院 2024-03-05 — — CN disclosed
CN-117299202-A Quaternary ammonium ion liquid hybridized MCM-41 solid base catalyst and preparation method thereof 常州大学 2023-12-29 — — CN disclosed
WO-2023125498-A1 ORGANIC COMPOUND, MIXTURE AND COMPOSITION COMPRISING SAME, ORGANIC ELECTRONIC DEVICE, AND APPLICATIONS OF COMPOUND 浙江光昊光电科技有限公司 2023-07-06 — — WO disclosed
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers L'OREAL S.A. (FR) 2006-04-27 — — US disclosed
US-20060085922-A1 Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant L'OREAL S.A. (FR) 2006-04-27 — — US disclosed
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant L'OREAL S.A. (FR) 2006-04-20 — — US disclosed
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles L'OREAL S.A. (FR) 2006-04-20 — — US disclosed
US-20060080792-A1 Film-forming composition for the cosmetic treatment of keratin materials comprising at least one electrophilic monomer and at least one non-silicone polymer L'OREAL S.A. (FR) 2006-04-20 — — US disclosed
US-20060078523-A1 Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair L'OREAL S.A. (FR) 2006-04-13 — — US disclosed
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt L'OREAL S.A. (FR) 2006-04-13 — — US disclosed
WO-2006024611-A2 STABILIZATION OF ORGANIC MATERIALS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-03-09 — — WO disclosed
US-6645991-B1 Glycoprotein adhesion receptor antagonists such as 3-phenyl-4-(4-(3-(pyridin-2-ylamino)propoxy)phenyl)-butyric acid, used for prophylaxis of tumors, osteoporosis, cardiovascular diseases, fibrosis, inflammation, infections or psoriasis MERCK PATENT GMBH (DE) 2003-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161277-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS MAPT 4066/4885PDCD1 2682/4885CD274 4512/4885
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers KRT18, CUTA, MARK1 MAPT 366/4885PDCD1 2073/4885CD274 1961/4885
US-12336982-B2 Compositions and methods of modulating short-chain dehydrogenase activity HPGD, GCDH, HPGDS MAPT 4066/4885PDCD1 2682/4885CD274 4512/4885
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles KRT18, PRKDC, ACP1 MAPT 355/4885PDCD1 2607/4885CD274 2263/4885
US-20060085922-A1 Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant KRT18, GPX4, NOX4 MAPT 2098/4885PDCD1 4576/4885CD274 4667/4885
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant MITF, CUTA, NACA MAPT 865/4885PDCD1 1137/4885CD274 1096/4885
US-20060078523-A1 Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair HOGA1, OAT, SUCLG1 MAPT 1711/4885PDCD1 1738/4885CD274 2670/4885
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt KRT18, DSG1, DSC1 MAPT 215/4885PDCD1 2957/4885CD274 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback